| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 86.64× | 86.64× | 80.50× | 78.43× | 80.87× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 3.31× | 3.57× | 3.65× | 3.60× | 3.38× | ||
| 1.56× | 1.56× | 1.67× | 1.66× | 1.58× | ||
| 1.05× | 1.05× | 1.00× | 0.96× | 0.99× | ||
| 0.72× | 0.72× | 0.73× | 0.69× | 0.71× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 80.87 | 78.43 | 80.50 | 86.64 | 86.64 | |
| Working Capital Turnover | 3.38 | 3.60 | 3.65 | 3.57 | 3.31 | |
| Asset Turnover | 1.58 | 1.66 | 1.67 | 1.56 | 1.56 | |
| Cash Conversion (CFO/Net Income) | 0.99 | 0.96 | 1.00 | 1.05 | 1.05 | |
| CFO/EBITDA | 0.71 | 0.69 | 0.73 | 0.72 | 0.72 |